Viracta Therapeutics, Inc. (VIRX) Financials
Stock symbol VIRX is outdated, potentially delisted? Maybe it is available on other exchange?
VIRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 56.7 million | 38.4 million |
| Sept. 30, 2023 | 66.4 million | 36.4 million |
| June 30, 2023 | 76.9 million | 36.1 million |
| March 31, 2023 | 85.8 million | 34.7 million |
VIRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -10.0 million | 1.8 million |
| Sept. 30, 2023 | -10.5 million | 1.8 million |
| June 30, 2023 | -8.2 million | 2.0 million |
| March 31, 2023 | -11.3 million | 2.1 million |
VIRX Net Income
No data available :(
VIRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 53.7 million | - | 282000 |
| Sept. 30, 2023 | 63.0 million | - | 381000 |
| June 30, 2023 | 72.9 million | - | 475000 |
| March 31, 2023 | 80.3 million | 22.8 million | 563000 |
VIRX Shares Outstanding
VIRX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | - | 9.4 million | 4.2 million | 123001 |
| Sept. 30, 2023 | 51000 | 8.2 million | 4.3 million | - |
| June 30, 2023 | 189000 | 8.2 million | 4.3 million | - |
| March 31, 2023 | 189000 | 7.6 million | 4.6 million | - |
VIRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | 123000 |
| Sept. 30, 2023 | - | 128000 |
| June 30, 2023 | - | 119000 |
| March 31, 2023 | - | 122000 |
VIRX
Price: $0.01
52 week price:
Earnings Per Share: -1.10 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 46946
Market Capitalization: 388698